Vectura Group Share Price (VEC)

166.35 -2.75 (-1.63%) delayed: 7:06PM BST
Bid price 166.00 Open price 169.00
Ask price 166.70 Prev close 166.20
High price 169.70 Spread 0.42%
Low price 164.98 Volume 1,609,682

Register now for FREE live Vectura Group share prices, Vectura Group stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Vectura Group Level 2 Data, indepth research tools and investor commentary for Vectura Group (VEC) and other London Stock Exchange equities.

Vectura Group Share Price Chart

Advanced Charts >>

Register now for FREE Vectura Group share price charts

Vectura Group Share Price Information

Name Vectura Group Epic VEC
Sector Pharmaceuticals & Biotechnology ISIN GB00B01D1K48
Activites Vectura Group plc develops inhaled therapies principally for the treatment of respiratory diseases. Vectura's main products target diseases such as asthma and chronic obstructive pulmonary disease (COPD), a growing market that is currently estimated to be worth in excess of $25bn. Vectura has seven products marketed by its partners and a portfolio of drugs in clinical and pre-clinical development, a number of which have been licensed to major pharmaceutical companies. Vectura has development collaborations and licence agreements with several pharmaceutical companies, including Novartis, Sandoz (the generics arm of Novartis), Baxter and GlaxoSmithKline (GSK). Vectura seeks to develop certain programmes itself where this will optimise value. Vectura's formulation and inhalation technologies are available to other pharmaceutical companies on an out-licensing basis where this complements Vectura's business strategy. Index FTSE 250

Vectura Group Key Numbers

Latest Share Price (p) 166.35 Net Gearing (%) -6.27
Market Capitalisation (£m) 694.21 Gross Gearing (%) 24.40
Shares in issue (m) 410.53 Debt Ratio 10.20
P/E Ratio 187.89 Debt-to-Equity Ratio 0.35
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.32
Dividend Yield (%) 0.00 Price to book value 3.13
Dividend cover (x) 0.00 ROCE (%) -2.51
Earning per share (p) 0.90 EPS Growth (%) 228.57
52 week high / low 200.00 / 145.30 DPS Growth (%) n/a

Vectura Group Director Deals

Dec.Date Type Director Pos No. of Shares
05/10/2015 TIN Dr Trevor Phillips ED 205,329
07/07/2015 BUY Dr Trevor Phillips ED 1,000
07/07/2015 BUY Andrew Oakley FD 1,000
17/04/2015 EXR Dr Christopher Blackwell RES 18,987
16/01/2015 EXR Dr Trevor Phillips ED 3,133

More Vectura Group Director Deals >>

Vectura Group Company News

12:00 26/05/2016

Form 8.5 (EPT/RI) - Vectura Group PLC

/* */ RNS Number : 3972Z Peel Hunt LLP 26 May 2016    FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")...

10:14 26/05/2016

Form 8.5 (EPT/RI) - Vectura Group PLC

/* */ RNS Number : 4004Z JPMorgan Securities Plc 26 May 2016   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")...

09:31 26/05/2016

Vectura Group substantially narrows FY pretax loss

Vectura Group has substantially narrowed its FY pretax loss to GBP1.9m, from a loss of GBP6.2m. Revenue was notably higher at GBP72m, from GBP58m. "I am pleased to report Vectura's continued strong financial and operational performance for the twelve months ended 31 March 2016," said CEO James...

More Vectura Group Company News >>

Register now for FREE Vectura Group company news

Vectura Group Share Price Discussions

more than 1 year ago

VECTURA (VEC)

Powered by IST's

Register now for FREE Vectura Group share price discussions